Age- and Gender-Related Serum Level of Interleukin 18 in Iranian Fars Ethnic Group with Metabolic Syndrome

dc.contributor.authorAghajani, Roja
dc.contributor.authorSaeidi, Mohsen
dc.contributor.authorAmiriani, Taghi
dc.contributor.authorMarjani, Majid
dc.contributor.authorMarjani, Abdoljalal
dc.date.accessioned2026-02-06T18:48:50Z
dc.date.issued2022
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractBackground: The purpose of the present study was to investigate the age- and gender-related serum level of interleukin 18 (IL18) in male and female Iranian Fars ethnic group with metabolic syndrome components. Methods: The study included 226 native Iranian Fars ethnic groups. One hundred sixteen females and 110 men were selected. There were 60 females and 50 males with metabolic syndrome and 56 females and 60 males without metabolic syndrome. The serum fasting blood glucose (FBS), lipid profiles, and IL18 were measured. The National Cholesterol Education Program Adult treatment Panel III criteria were used to determine metabolic syndrome components. Results: There were significant differences between the males and females [except high-density lipoprotein (HDL)] with and without metabolic syndrome for the mean body mass index, FBS, HDL-cholesterol, waist circumference (WC), triglyceride (TG), and IL18 levels in all age groups. Serum IL18 was the highest in males and females in age groups 61-70 and 41-50 years with metabolic syndrome, respectively. Serum IL18 levels significantly correlated with TG and waist WC in males (and also correlated with HDL) and females with the metabolic syndrome. There were significant correlations between IL18 and TG and WC in males (and also correlated with HDL) in ages 61-70 years and females in ages 41-50 years with the metabolic syndrome. Conclusions: The increased IL18 level in both gender and different ages may have an important role in the alteration of some metabolic syndrome components. These alterations may be made to happen in different related metabolic diseases. IL18 seems to be a useful biomarker for the management of metabolic syndrome components and the risk factors of cardiovascular disease.
dc.identifier.doi10.1089/met.2021.0058
dc.identifier.endpage49
dc.identifier.issn1540-4196
dc.identifier.issn1557-8518
dc.identifier.issue1
dc.identifier.orcid0000-0002-0399-6160
dc.identifier.pmid34724802
dc.identifier.scopus2-s2.0-85125001154
dc.identifier.scopusqualityQ3
dc.identifier.startpage43
dc.identifier.urihttps://doi.org/10.1089/met.2021.0058
dc.identifier.urihttps://hdl.handle.net/11129/14623
dc.identifier.volume20
dc.identifier.wosWOS:000715777200001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherMary Ann Liebert, Inc
dc.relation.ispartofMetabolic Syndrome and Related Disorders
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260204
dc.subjectage
dc.subjectgender
dc.subjectinterleukin 18
dc.subjectmetabolic syndrome
dc.subjectIranian Fars
dc.titleAge- and Gender-Related Serum Level of Interleukin 18 in Iranian Fars Ethnic Group with Metabolic Syndrome
dc.typeArticle

Files